uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder – Possible Clinical Implications-Reference-Cited by-同舟云学术

uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder – Possible Clinical Implications

Published:2015-08-20 Issue:8 Volume:10 Page:e0135824
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dohn Line Hammer,Pappot Helle,Iversen Benedikte Richter,Illemann Martin,Høyer-Hansen Gunilla,Christensen Ib Jarle,Thind Peter,Salling Lisbeth,von der Maase Hans,Laerum Ole Didrik

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Plasminogen activation and cancer;K Danø;Thromb Haemost,2005

2. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder;LH Dohn;Urol Oncol,2015

3. Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer;M Illemann;Cancer Med,2014

4. Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry;OD Laerum;Int J Cancer,2012

5. Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma;W Alpizar-Alpizar;Int J Cancer,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma;BMC Urology;2023-10-24

2. SuPARnostic: An Advanced Predictive Tool for Detecting Recurrence in Renal Cell Carcinoma;EMJ Urology;2023-04-20

3. Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature;International Journal of Nanomedicine;2022-09

4. Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy;Cancers;2022-03-18

5. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer;Journal of Translational Medicine;2022-03-18